Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/31737
Title: A low serum alkaline phosphatase may signal hypophosphatasia in osteoporosis clinic patients.
Austin Authors: Ng, Elisabeth;Ashkar, Claudia;Seeman, Ego ;Schneider, Hans G;Nguyen, Hanh;Ebeling, Peter R;Sztal-Mazer, Shoshana
Affiliation: Department of Endocrinology & Diabetes, Alfred Health, Melbourne, Australia.
Department of Endocrinology & Diabetes, Alfred Health, Melbourne, Australia.
Department of Medicine, University of Melbourne, Melbourne, Australia.
Department of Endocrinology & Diabetes, Alfred Health, Melbourne, Australia.
Endocrinology
Department of Endocrinology, Monash Health, Clayton, Australia.
Issue Date: 2023
Date: 2022
Publication information: Osteoporosis International 2023; 34(2)
Abstract: Low serum alkaline phosphatase (ALP) was found in 9% of patients attending an osteoporosis clinic, 0.6% of hospital patients, and 2/22 with an atypical femoral fracture. Hypophosphatasia was diagnosed in 3% of osteoporosis clinic patients with low ALP. Low ALP is a screening tool for hypophosphatasia, a condition potentially aggravated by antiresorptive therapy.
URI: https://ahro.austin.org.au/austinjspui/handle/1/31737
DOI: 10.1007/s00198-022-06597-3
ORCID: 0000-0001-6649-032X
Journal: Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
PubMed URL: 36434431
ISSN: 1433-2965
Type: Journal Article
Subjects: Alkaline phosphatase
Bisphosphonate
Hypophosphatasemia
Hypophosphatasia
Osteoporosis
Appears in Collections:Journal articles

Show full item record

Page view(s)

58
checked on Oct 2, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.